Vitamin C and Mast Cell Activation: A Tentative, Evidence-Based Look

By Brooke Simmons, Registered Nurse – The Health Lodge

Understanding MCAS and the Challenges of Immune Regulation

Mast Cell Activation Syndrome (MCAS) is a complex inflammatory condition in which mast cells become hyper-reactive, releasing excessive histamine, mediators and cytokines, often resulting in symptoms like flushing, itching, abdominal pain, brain fog, fatigue, and anxiety. In many MCAS cases, patients struggle with chronic inflammation, oxidative stress, histamine overload, and immune dysregulation.

How Vitamin C Might Support Mast Cell-Related Balance: Mechanisms & Preliminary Evidence

1. Antioxidant and Anti-Inflammatory Actions

   Vitamin C is widely recognised as a potent antioxidant, able to neutralise reactive oxygen species (ROS) and reduce oxidative stress, which is known to trigger or worsen immune-cell activation including mast cells. By lowering oxidative stress, vitamin C may indirectly reduce one of the upstream “triggers” of mast-cell degranulation.

   Beyond ROS neutralisation, vitamin C also supports cellular health, immune-cell function, and tissue resilience, factors that may help the body manage chronic inflammatory or immune burden, which often underlies or exacerbates MCAS symptoms.

2. Possible Modulation of Histamine and Mediator Release

   Some experimental studies suggest that vitamin C may influence mast-cell behaviour, including mediator release. For example, research in immunology and allergy models has observed that ascorbate can attenuate release of histamine and other mediators from mast-cell analogues under stimulatory conditions.

   This raises the possibility that adequate vitamin C status could reduce histamine burden and lower mast-cell reactivity, especially in situations of repeated triggers, oxidative stress, or inflammatory overload.

3. Immune-Support and Tissue Health

   Vitamin C supports connective tissue integrity, epithelial barriers, and circulatory / vascular health, which may benefit people with MCAS as barrier dysfunction (gut lining, vascular permeability, skin) or endothelial stress often contribute to symptom flares. Good tissue health helps limit unnecessary immune activation, histamine leakage, and systemic inflammation.

   Moreover, by supporting general immune resilience and antioxidant defence, vitamin C may contribute to a more regulated, less hyper-reactive immune-environment over time.

Integrative Clinical Insight: How Vitamin C Could Be Used Carefully in MCAS Protocols

Given its safety profile, cost, and broad physiological support, vitamin C may be considered as part of a comprehensive MCAS support plan, especially in individuals with:

• Evidence of oxidative stress or recurrent inflammatory burden;
• Histamine intolerance or signs of mediator overload;
• Gut, skin, or vascular barrier challenges;
• Nutrient depletion, poor dietary antioxidant intake, or high metabolic demand.

Implementation might include: ensuring adequate dietary vitamin C intake (fruits/vegetables), supplementation, IV therapy,  lifestyle changes (stress, sleep, environmental/trigger reduction), and symptom monitoring.

Importantly: any supplementation should be supervised by a qualified practitioner, with attention to dose, individual context, and interaction with other interventions.

References

1. Carr, A. C., & Maggini, S. (2017). Vitamin C and immune function. Nutrients, 9(11), 1211. https://doi.org/10.3390/nu9111211
2. Hagel, A. F., Layritz, C. M., Hagel, W. H., et al. (2013). Intravenous infusion of ascorbic acid decreases serum histamine concentrations in patients with allergic and non-allergic diseases. Naunyn-Schmiedeberg’s Archives of Pharmacology, 386(9), 789–793. https://doi.org/10.1007/s00210-013-0880-1
3. Hemilä, H. (2017). Vitamin C and infections. Nutrients, 9(4), 339. https://doi.org/10.3390/nu9040339
4. Kazama, I., Sato, Y., & Tamada, T. (2022). Pyridoxine synergistically potentiates mast cell-stabilizing property of ascorbic acid. Cellular Physiology and Biochemistry, 56(3), 282–292. https://doi.org/10.33594/000000534
5. Suh, S. Y., Bae, W. K., Ahn, H. Y., et al. (2012). Intravenous vitamin C administration reduces fatigue in office workers: A double-blind randomized controlled trial. Nutrition Journal, 11, 7. https://doi.org/10.1186/1475-2891-11-7
6. Vollbracht, C., & Kraft, K. (2021). Feasibility of vitamin C in the treatment of post-viral fatigue with focus on long COVID, based on a systematic review of IV vitamin C on fatigue. Nutrients, 13(4), 1154. https://doi.org/10.3390/nu13041154
7. Vollbracht, C., Raithel, M., Krick, B., Kraft, K., & Hagel, A. F. (2018). Intravenous vitamin C in the treatment of allergies: An interim subgroup analysis of a long-term observational study. Journal of International Medical Research, 46(9), 3640–3655. https://doi.org/10.1177/0300060518777044